Book contents
- Case Studies in Neuropalliative Care
- Case Studies in Neuropalliative Care
- Copyright page
- Contents
- Contributors
- Section 1 Palliative Care Principles
- Section 2 Cerebrovascular Diseases
- Section 3 Neurodegenerative and Neuromuscular Diseases
- Section 4 Neuro-oncology
- Section 5 Pediatric Neurology
- Section 6 Demyelinating Diseases and Autoimmune Neurology
- Index
- References
Section 3 - Neurodegenerative and Neuromuscular Diseases
Published online by Cambridge University Press: 08 June 2018
Edited by
Book contents
- Case Studies in Neuropalliative Care
- Case Studies in Neuropalliative Care
- Copyright page
- Contents
- Contributors
- Section 1 Palliative Care Principles
- Section 2 Cerebrovascular Diseases
- Section 3 Neurodegenerative and Neuromuscular Diseases
- Section 4 Neuro-oncology
- Section 5 Pediatric Neurology
- Section 6 Demyelinating Diseases and Autoimmune Neurology
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Case Studies in Neuropalliative Care , pp. 75 - 112Publisher: Cambridge University PressPrint publication year: 2018
References
Suggested Reading
Miyasaki, JM, Long, J, Mancini, D, et al. Palliative care for advanced Parkinson disease: An interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism & Related Disorders. 2012;18 Suppl. 3:S6–9.CrossRefGoogle ScholarPubMed
Miyasaki, JM. Palliative care in Parkinson’s disease. Current Neurology and Neuroscience Reports. 2013;13(8):367.CrossRefGoogle ScholarPubMed
Miyasaki, JM, Kluger, B. Palliative care for Parkinson’s disease: Has the time come? Current Neurology and Neuroscience Reports. 2015;15(5):26.CrossRefGoogle ScholarPubMed
Wiblin, L, Lee, M, Burn, D. Palliative care and its emerging role in multiple system atrophy and progressive supranuclear palsy. Parkinsonism & Related Disorders. 2017;34:7–14.CrossRefGoogle ScholarPubMed
Veronese, S, Gallo, G, Valle, A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Supportive & Palliative Care. 2017;7(2):164–72.CrossRefGoogle ScholarPubMed
Goy, ER, Carter, J, Ganzini, L. Neurologic disease at the end of life: Caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis. Journal of Palliative Medicine. 2008;11(4):548–54.CrossRefGoogle ScholarPubMed
Strupp, J, Kunde, A, Galushko, M, Voltz, R, Golla, H. Severely affected by Parkinson disease: The patient’s view and implications for palliative care. The American Journal of Hospice & Palliative Care. 2017:1049909117722006.CrossRefGoogle Scholar
Boersma, I, Jones, J, Carter, J, et al. Parkinson disease patients’ perspectives on palliative care needs: What are they telling us? Neurology Clinical Practice. 2016;6(3):209–19.CrossRefGoogle ScholarPubMed
Kluger, BM, Fox, S, Timmons, S, et al. Palliative care and Parkinson’s disease: Meeting summary and recommendations for clinical research. Parkinsonism & Related Disorders. 2017;37:19–26.CrossRefGoogle ScholarPubMed
Giles, S, Miyasaki, J. Palliative stage Parkinson’s disease: Patient and family experiences of health-care services. Palliative Medicine. 2009;23(2):120–5.CrossRefGoogle ScholarPubMed
Hasson, F, Kernohan, WG, McLaughlin, M, et al. An exploration into the palliative and end-of-life experiences of carers of people with Parkinson’s disease. Palliative Medicine. 2010;24(7):731–6.CrossRefGoogle ScholarPubMed
McLaughlin, D, Hasson, F, Kernohan, WG, et al. Living and coping with Parkinson’s disease: Perceptions of informal carers. Palliative Medicine. 2011;25(2):177–82.CrossRefGoogle ScholarPubMed
Boersma, I, Jones, J, Coughlan, C, et al. Palliative care and Parkinson’s disease: Caregiver perspectives. Journal of Palliative Medicine. 2017;20(9):930–8.CrossRefGoogle ScholarPubMed
Richfield, EW, Jones, EJ, Alty, JE. Palliative care for Parkinson’s disease: A summary of the evidence and future directions. Palliative Medicine. 2013;27(9):805–10.CrossRefGoogle ScholarPubMed
Buter, TC, van den Hout, A, Matthews, FE, Larsen, JP, Brayne, C, Aarsland, D. Dementia and survival in Parkinson disease: A 12-year population study. Neurology. 2008;70(13):1017–22.CrossRefGoogle ScholarPubMed
Savica, R, Grossardt, BR, Bower, JH, et al. Survival and causes of death among people with clinically diagnosed synucleinopathies with Parkinsonism: A population-based study. JAMA Neurology. 2017;74(7):839–46.CrossRefGoogle ScholarPubMed
Teno, JMGP, Lee, IC, Kuo, S, Spence, C, Connor, S, Casarett, D. Does hospice improve quality of care for persons dying from dementia? Journal of the American Geriatric Society. 2011;59(8):1531–6.CrossRefGoogle ScholarPubMed
Mitchell, SL, Teno, JM, Kiely, DK, et al. The clinical course of advanced dementia. The New England Journal of Medicine. 2009;361(16):1529–38.CrossRefGoogle ScholarPubMed
Mohamed, S, Rosenheck, R, Lyketsos, CG, Schneider, LS. Caregiver burden in Alzheimer disease: Cross-sectional and longitudinal patient correlates. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry. 2010;18(10):917–27.CrossRefGoogle ScholarPubMed
Gaugler, JE, Kane, RL, Kane, RA, Newcomer, R. Unmet care needs and key outcomes in dementia. Journal of the American Geriatric Society. 2005;53(12):2098–2105.CrossRefGoogle ScholarPubMed
Shega, JW, Levin, A, Hougham, GW, et al. Palliative Excellence in Alzheimer Care Efforts (PEACE): A program description. Journal of Palliative Medicine. 2003;6(2):315–20.CrossRefGoogle Scholar
Sampson, EL, Candy, B, Davis, S, et al. Living and dying with advanced dementia: A prospective cohort study of symptoms, service use and care at the end of life. Palliative Medicine. 2017:269216317726443.CrossRefGoogle Scholar
Hanson, E, Hellstrom, A, Sandvide, A, et al. The extended palliative phase of dementia – An integrative literature review. Dementia (London, England). 2016.CrossRefGoogle Scholar
Hendriks, SA, Smalbrugge, M, Hertogh, CM, van der Steen, JT. Dying with dementia: Symptoms, treatment, and quality of life in the last week of life. Journal of Pain and Symptom Management. 2014;47(4):710–20.CrossRefGoogle ScholarPubMed
Monroe, TB, Carter, MA, Feldt, KS, Dietrich, MS, Cowan, RL. Pain and hospice care in nursing home residents with dementia and terminal cancer. Geriatrics & Gerontology International. 2013;13(4):1018–25.CrossRefGoogle ScholarPubMed
Finucane, TE, Christmas, C, Travis, K. Tube feeding in patients with advanced dementia: A review of the evidence. JAMA. 1999;282(14):1365–70.CrossRefGoogle ScholarPubMed
McCann, R. Lack of evidence about tube feeding – Food for thought. JAMA. 1999;282(14):1380–1.CrossRefGoogle ScholarPubMed
Mitchell, SL, Mor, V, Gozalo, PL, Servadio, JL, Teno, JM. Tube feeding in US nursing home residents with advanced dementia, 2000–2014. JAMA. 2016;316(7):769–70.CrossRefGoogle ScholarPubMed
Teno, JM, Gozalo, PL, Mitchell, SL, et al. Does feeding tube insertion and its timing improve survival? Journal of the American Geriatric Society. 2012;60(10):1918–21.CrossRefGoogle ScholarPubMed
Miller, SC, Lima, JC, Mitchell, SL. Influence of hospice on nursing home residents with advanced dementia who received Medicare-skilled nursing facility care near the end of life. ? Journal of the American Geriatric Society. 2012;60(11):2035–41.CrossRefGoogle ScholarPubMed
Kiely, DK, Givens, JL, Shaffer, ML, Teno, JM, Mitchell, SL. Hospice use and outcomes in nursing home residents with advanced dementia. Journal of the American Geriatric Society. 2010;58(12):2284–91.CrossRefGoogle ScholarPubMed
de Visser, M, Oliver, DJ. Palliative care in neuromuscular diseases. Current Opinion in Neurology. 2017.CrossRefGoogle Scholar
Bourke, SC, Tomlinson, M, Williams, TL, Bullock, RE, Shaw, PJ, Gibson, GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial. The Lancet Neurology. 2006;5(2):140–7.Google ScholarPubMed
Miller, RG, Jackson, CE, Kasarskis, EJ, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26.Google Scholar
Hobson, EV, McDermott, CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nature Reviews Neurology. 2016;12(9):526–38.CrossRefGoogle ScholarPubMed
Elman, LB, Houghton, DJ, Wu, GF, Hurtig, HI, Markowitz, CE, McCluskey, L. Palliative care in amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Journal of Palliative Medicine. 2007;10(2):433–57.CrossRefGoogle ScholarPubMed
Karam, CY, Paganoni, S, Joyce, N, Carter, GT, Bedlack, R. Palliative care issues in amyotrophic lateral sclerosis: An evidenced-based review. The American Journal of Hospice & Palliative Care. 2016;33(1):84–92.CrossRefGoogle ScholarPubMed
Hwang, CS, Weng, HH, Wang, LF, Tsai, CH, Chang, HT. An eye-tracking assistive device improves the quality of life for ALS patients and reduces the caregivers’ burden. Journal of Motor Behavior. 2014;46(4):233–8.CrossRefGoogle ScholarPubMed
de Wit, J, Bakker, LA, van Groenestijn, AC, et al. Caregiver burden in amyotrophic lateral sclerosis: A systematic review. Palliative Medicine. 2017:269216317709965.CrossRefGoogle Scholar
Suggested Reading
Phillips, LJ. Dropping the bomb: The experience of being diagnosed with Parkinson’s disease. Geriatr Nurs. 2006;27:362–9.CrossRefGoogle ScholarPubMed
Boersma, I, Jones, J, Carter, J, et al. Parkinson disease patients’ perspectives on palliative care needs: What are they telling us? Neurol Clin Pract. 2016;6:209–19.CrossRefGoogle ScholarPubMed
Baile, WF, Buckman, R, Lenzi, R, Glober, G, Beale, EA, Kudelka, AP. SPIKES – A six-step protocol for delivering bad news: Application to the patient with cancer. Oncologist. 2000;5:302–11.CrossRefGoogle Scholar
Jacobsen, JC, Zhang, B, Block, SD, Maciejewski, PK, Prigerson, HG. Distinguishing symptoms of grief and depression in a cohort of advanced cancer patients. Death Stud. 2010;34:257–73.CrossRefGoogle Scholar
Creutzfeldt, CJ, Robinson, MT, Holloway, RG. Neurologists as primary palliative care providers: Communication and practice approaches. Neurol Clin Pract. 2016;6:40–8.CrossRefGoogle ScholarPubMed
Suggested Reading
Snineh, MA, Camicioli, R, Miyasaki, JM. Decisional capacity for advanced care directives in Parkinson’s disease with cognitive complaints. Parkinsonism Relat Disord. In press.Google Scholar
Tuck, KK, Brod, L, Nutt, J, Fromme, EK. Preferences of patients with Parkinson’s disease for communication about advanced care planning. Am J Hosp Palliat Care. 2015;32:68–77.CrossRefGoogle ScholarPubMed
Hely, MA, Reid, WG, Adena, MA, Halliday, GM, Morris, JG. The Sydney multicenter study of Parkinson’s disease: The inevitability of dementia at 20 years. Mov Disord. 2008;23:837–44.CrossRefGoogle Scholar
Miyasaki, JM, Kluger, B. Palliative care for Parkinson’s disease: Has the time come? Current Neurology and Neuroscience Reports. 2015;15:26.CrossRefGoogle ScholarPubMed
Boersma, I, Miyasaki, J, Kutner, J, Kluger, B. Palliative care and neurology: Time for a paradigm shift. Neurology. 2014;83:561–7.CrossRefGoogle ScholarPubMed
Goy, ER, Bohlig, A, Carter, J, Ganzini, L. Identifying predictors of hospice eligibility in patients with Parkinson disease. Am J Hosp Palliat Care. 2015;32:29–33.CrossRefGoogle ScholarPubMed
Suggested Reading
Aarsland, D, Marsh, L, Schrag, A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord. 2009 Nov 15;24(15):2175–86.CrossRefGoogle ScholarPubMed
Aarsland, D, Kurz, MW. The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol. 2010 May;20(3):633–9.CrossRefGoogle ScholarPubMed
Factor, SA, Bennett, A, Hohler, AD, Wang, D, Miyasaki, JM. Quality improvement in neurology: Parkinson disease update quality measurement set. Neurology. 2016 Jun 14;86(24):2278–83.CrossRefGoogle ScholarPubMed
Miyasaki, JM, Martin, W, Suchowersky, O, Weiner, WJ, Lang, AE. Practice parameter: Initiation of treatment for Parkinson’s disease: An evidence-based review: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002 Jan 8;58(1):11–17.CrossRefGoogle Scholar
Pondal, M, Marras, C, Miyasaki, J, Moro, E, Armstrong, MJ, Strafella, AP, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130–5.CrossRefGoogle Scholar
Tomlinson, CL, Stowe, R, Patel, S, Rick, C, Gray, R, Clarke, CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010 Nov 15;25(15):2649–53.CrossRefGoogle ScholarPubMed
Miyasaki, JM, Grimes, D, Lang, AE. Acute delirium after withdrawal of amantadine in Parkinson’s disease. Neurology. 1999 May 12;52(8):1720–1.CrossRefGoogle ScholarPubMed
Svenningsson, P, Westman, E, Ballard, C, Aarsland, D. Cognitive impairment in patients with Parkinson’s disease: Diagnosis, biomarkers, and treatment. Lancet Neurol. 2012 Aug;11(8):697–707.CrossRefGoogle ScholarPubMed
Cummings, J, Emre, M, Aarsland, D, Tekin, S, Dronamraju, N, Lane, R. Effects of rivastigmine in Alzheimer’s disease patients with and without hallucinations. J Alzheimers Dis. 2010;20(1):301–11.CrossRefGoogle ScholarPubMed
Larsson, V, Engedal, K, Aarsland, D, Wattmo, C, Minthon, L, Londos, E. Quality of life and the effect of memantine in dementia with Lewy bodies and Parkinson’s disease dementia. Dement Geriatr Cogn Disord. 2011;32(4):227–34.CrossRefGoogle ScholarPubMed
Miyasaki, JM, Shannon, K, Voon, V, Ravina, B, Kleiner-Fisman, G, Anderson, K, et al. Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006 Apr 11;66(7):996–1002.CrossRefGoogle Scholar
Suggested Reading
Abu Snineh, M, Camicioli, R, Miyasaki, JM. Decisional capacity for advanced care directives in Parkinson’s disease with cognitive concerns. Parkinsonism Relat Disord.Google Scholar
Suggested Reading
Miyasaki, JM, Shannon, K, Voon, V, Ravina, B, Kleiner-Fisman, G, Anderson, K, et al. Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006 Apr 11;66(7):996–1002.Google Scholar
Cummings, J, Isaacson, S, Mills, R, Williams, H, Chi-Burris, K, Corbett, A, et al. Pimavanserin for patients with Parkinson’s disease psychosis: A randomised, placebo-controlled phase 3 trial. Lancet. 2014 Feb 8;383(9916):533–40.CrossRefGoogle ScholarPubMed
Suggested Reading
Zesiewicz, TA, Sullivan, KL, Arnulf, I, Chaudhuri, KR, Morgan, JC, Gronseth, GS, et al. Practice parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010 Mar 16;74(11): 924–31.CrossRefGoogle Scholar
Suggested Reading
Navaid, M, Melvin, T, Berube, J, Dotson, S. Principles of wound care in hospice and palliative medicine. Am J Hosp Palliat Care. 2010;27(5):337.CrossRefGoogle ScholarPubMed
Eisler, T, Eng, N, Plotkin, C, Calne, DB. Absorption of levodopa after rectal administration. Neurology. 1981;31(2):215–17.Google Scholar
Vogelzang, JMJ, Luinstra, M, Rutgers, AWF. Effect of rectal levodopa administration: A case report. Case Reports in Neurology. 2015;7(3):209–12.CrossRefGoogle ScholarPubMed
Suggested Reading
Holloway, RG, Gramling, R, Kelly, AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013 Feb 19;80(8):764–72.CrossRefGoogle ScholarPubMed
Wiblin, L, Lee, M, Burn, D. Palliative care and its emerging role in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 Jan;34:7–14. Epub 2016 Oct 19.Google Scholar
Nielsen, MK, Neergaard, MA, Jensen, AB, Bro, F, Guldin, MB. Do we need to change our understanding of anticipatory grief in caregivers? A systematic review of caregiver studies during end-of-life caregiving and bereavement. Clin Psychol Rev. 2016 Mar;44:75–93. Epub 2016 Jan 8.CrossRefGoogle ScholarPubMed
Suggested Reading
Weidner, NJ. Developing an interdisciplinary palliative care plan for the patient with muscular dystrophy. Pediatr Ann. 2005 Jul;34(7):546–52.CrossRefGoogle ScholarPubMed
Carter, GT, Joyce, NC, Abresch, AL, Smith, AE, et al. Using palliative care in progressive neuromuscular disease to maximize quality of life. Phys Med Rehabil Clin N Am. 2012 Nov;23(4):903–9. doi:10.1016/j.pmr.2012.08.002. Epub 2012 Oct 17.CrossRefGoogle ScholarPubMed
Creutzfeldt, CJ, Robinson, MT, Holloway, RG. Neurologists as primary palliative care providers: Communication and practice approaches. Neurol Clin Pract. 2016 Feb;6(1):40–8.CrossRefGoogle ScholarPubMed
Kluger, BM, Fox, S, Timmons, S, Katz, M, et al. Palliative care and Parkinson’s disease: Meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017 Jan 11.CrossRefGoogle Scholar
Landfeldt, E, Lindgren, P, Bell, CF, Guglieri, M, et al. Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol. 2016 May;263(5):906–15. doi:10.1007/s00415-016-8080-9. Epub 2016 Mar 10.CrossRefGoogle ScholarPubMed
US Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare Hospice Benefits. CMS Product No. 02154. 2016 Feb.Google Scholar
Suggested Reading
Nichols, N, Van Dyke, J, Nashold, L, Satriotomo, I, et al. Ventilatory control in ALS. Respir Physiol Neurobiol. 2013 Nov 1;189(2):429–37. doi:10.1016/j.resp.2013.05.016. Epub 2013 May 18.Google Scholar
Miller, RG, Jackson, CE, Kasarskis, EJ, England, JD, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence based review) report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009 Oct 13;73:1218–26.Google Scholar
Bach, J, Bakshiyev, R, Hon, A. Noninvasive respiratory management for patients with spinal cord injury and neuromuscular disease. Tanaffos. 2012;11(1):7–11.Google ScholarPubMed
Nicolini, A, Banfi, P, Grecchi, B, Lax, A, et al. Non-invasive ventilation in the treatment of sleep-related breathing disorders: A review and update. Rev Port Pneumol. 2014 Nov–Dec;20(6):324–35. doi:10.1016/j.rppneu.2014.03.009. Epub 2014 Jun 20.CrossRefGoogle ScholarPubMed
Yeow, M, Szmuilowicz, E. Practical aspects of using noninvasive positive pressure ventilation at the end of life #231. J Palliat Med. 2010 Sep;13(9):1150–1. doi:10.1089/jpm.2010.9787.Google Scholar
Heritier Barras, A, Adler, D, Iancu Ferfoglia, R, Ricou, B, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly. 201;143:w13830. doi:10.4414/smw.2013.13830.Google Scholar
Quill, C, Quill, T. Palliative use of noninvasive ventilation: Navigating murky waters. J Palliat Med. 2014 Jun;17(6):657–61. doi:10.1089/jpm.2014.0010. Epub 2014 May 13.CrossRefGoogle ScholarPubMed
Curtis, JR, Cook, DJ, Sinuff, T, White, D, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy. Crit Care Med. 2007 Mar;35(3):932–9.Google Scholar
Suggested Reading
Mitsumoto, H, Rabkin, JG. Palliative care for patients with amyotrophic lateral sclerosis – “Prepare for the worst and hope for the best.” JAMA. 2007; 298(2): 207–16.CrossRefGoogle Scholar
Kaub-Wittemer, D, von Steinbuchel, N, Wasner, M, Laier-Groeneveld, G, Borasio, GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. Journal of Pain and Symptom Management. 2003; 26(4): 890–6.CrossRefGoogle ScholarPubMed
Ganzini, L, Johnston, WS, Silveira, MJ. The final month of life in patients with ALS. Neurology. 2002; 59(3): 428–31.Google Scholar
Suggested Reading
Warden, V, Hurley, AC, Volicer, L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003 Jan–Feb; 4(1):9–15.Google Scholar
Heiskanen, T, Mätzke, S. Transdermal fentanyl in cachectic cancer patients. Pain. 2009 Jul;144(1–2):218–22. doi: 10.1016/j.pain.2009.04.012. Epub 2009 May 12.CrossRefGoogle ScholarPubMed
Dougherty, M, Harris, PS, Teno, J. Hospice care in assisted living facilities versus at home: Results of a multisite cohort study. J Am Geriatr Soc. 2015 Jun;63(6):1153–7.CrossRefGoogle ScholarPubMed
Malara, A. Pain assessment in elderly with behavioral and psychological symptoms of dementia. J Alzheimers Dis. 2016;50(4):1217–25.CrossRefGoogle ScholarPubMed
Tan, EC, Jokanovic, N. Prevalence of analgesic use and pain in people with and without dementia or cognitive impairment in aged care facilities: A systematic review and meta-analysis. Curr Clin Pharmacol. 2015;10(3):194–203.CrossRefGoogle ScholarPubMed
Van Kooten, J, Smalbrugge, M, Prevalence of pain in nursing home residents: The role of dementia stage and dementia subtypes. J Am Med Dir Assoc. 2017 Feb 21.Google Scholar
Suggested Reading
Casarett, DJ, Inouye, SK. Diagnosis and management of delirium near the end of life. Annals of Internal Medicine. 2001;135(1):32–40.Google Scholar
Lonergan, E, Luxenberg, J. Benzodiazepines for delirium. Cochrane Database Systematic Review. 2009 Oct 7.CD006379.CrossRefGoogle Scholar
Hshieh, TT, Yue, J, Effectiveness of multicomponent nonpharmacological delirium interventions: A meta-analysis. JAMA Intern Med. 2015 Apr;175(4):512–20.CrossRefGoogle ScholarPubMed
Markowitz, J, Narasimhan, M. Delirium and antipsychotics: A systematic review of epidemiology and somatic treatment options. Psychiatry (Edgmont). 2008 Oct;5(10):29–36.Google Scholar
Ozbolt, LB, Paniagua, MA, Kaiser, RM. Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc. 2008 Jan;9(1):18–28.CrossRefGoogle ScholarPubMed
Rao, S, Ferris, FD, Irwin, SA. Ease of screening for depression and delirium in patients enrolled in inpatient hospice care. J Palliat Med. 2011 Mar;14(3): 275–9.CrossRefGoogle ScholarPubMed
Susan, B, LeGrand, MD, Delirium in palliative medicine: A review. Journal of Pain and Symptom Management. 2012 Oct;44(4):583–94.Google Scholar
Video: Severity & scope guidance – antipsychotic medication use in nursing homes. http://surveyortraining.cms.hhs.gov/pubs/VideoInformation.aspx?id=40&cid=0CMSAPSYMEDUNH_SASG.Google Scholar